Biotechnology - Asia-Pacific, North America

Filter

Current filters:

Asia-PacificNorth America

Popular Filters

AstraZeneca to fork out $815 million for rights to anemia drug candidate

31-07-2013

In yet another move to boost its R&D pipeline, Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered…

Asia-PacificASP1517Astellas PharmaAstraZenecaBiotechnologyFG-4592FibroGenLicensingNephrology and HepatologyNorth AmericaPharmaceuticalResearch

Call for strong Trans-Pacific intellectual property framework from PhRMA

05-03-2013

The Pharmaceutical Research and Manufacturers of America (PhRMA) this week called on nations participating…

Asia-PacificBiotechnologyNorth AmericaPatentsPharmaceuticalSouth America

Celgene's Revlimid approved in China for MM; gets PDUFA date in USA for mantle cell lymphoma

12-02-2013

Celgene Corp's (Nasdaq: CELG) European subsidiary revealed that Revlimid (lenalidomide) has been granted…

Asia-PacificBiotechnologyCelgeneNorth AmericaOncologyRegulationRevlimid

Canada's Pharmascience sets up JV with Korea Kolmar; buys Rivex

03-01-2013

Privately-held Canadian drugmaker Pharmascience and Korea Kolmar Holdings, based in Seoul, South Korea,…

Asia-PacificBiotechnologyGenericsHelix BioPharmaKorea KolmarMergers & AcquisitionsNeurologicalNorth AmericaPharmaceuticalPharmascienceRivex Pharma

$210 financing for Intarcia's for diabetes product; and China's Innovent raises $25 million

19-11-2012

California, USA-based Intarcia Therapeutics last week announced the simultaneous completion of two financings…

Asia-PacificBiotechnologyFinancialInnovent BiologicsIntarcia TherapeuticsNorth AmericaPharmaceuticalProductionResearch

Regulatory briefs: Celgene's pomalidomide; Lundbeck's vortioxetine

21-09-2012

US biotech firm Celgene (Nasdaq: CELG) says that the US Food and Drug Administration's Oncologic Drugs…

Asia-PacificBiotechnologyCelgeneLundbeckNeurologicalNorth AmericaOncologyPharmaceuticalpomalidomideRegulationvortioxetine

US and Indian biotech industry find common ground on key issues

13-09-2012

The third annual BIO India conference kicked off yesterday in Mumbai with significant agreement among…

Asia-PacificBiotechnologyNorth AmericaPatentsRegulationResearch

J&J's Janssen files Xarelto with FDA for new indication; buys Chinese firm

03-05-2012

US health care major Johnson & Johnson's (NYSE: JNJ) subsidiary Janssen Research & Development says it…

Asia-PacificBayerBioseal BiotechBiotechnologyCardio-vascularJanssenJohnson & JohnsonMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationXarelto

Back to top